Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study.

The pharmacogenomics journal - 1 Aug 2014

Toh D S L, Tan L L, Aw D C W, Pang S M, Lim S H, Thirumoorthy T, Lee H Y, Tay Y K, Tan S K, Vasudevan A, Lateef A, Chong Y Y, Chan Y C, Loke C, Chan C L, Koay E S C, Ren E C, Lee E J D, Sung C

Abstract excerpt

To study the possible genetic associations with adverse drug reactions (ADR), the Singapore Health Sciences Authority (HSA) has piloted a program to collect DNA and phenotype data of ADR cases as part of its pharmacovigilance program. Between 2009 and 2012, HSA screened 158 cases of Stevens-Johns...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamazepine
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exanthema

Share to HLA-B Antigens

Share to Pharmacogenetics

Share to Pilot Projects

Share to Singapore

Share to Stevens-Johnson Syndrome

Source

Identifiers

PMID: 24394201
DOI: 10.1038/tpj.2013.46

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24394201-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study.PMID 24394201Read ↗

Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-CareSemantic proximity Read ↗

Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.Semantic proximity Read ↗

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.Semantic proximity Read ↗

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.Semantic proximity Read ↗

HLA-B Genotyping to Detect Carbamazepine-Induced Stevens-Johnson Syndrome: Implications for Personalizing MedicineSemantic proximity Read ↗

Pharmacogenetics of toxic epidermal necrolysis.Semantic proximity Read ↗

Impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA-B*1502 genotyping in Taiwan, 2000-2017: A nationwide longitudinal study.Semantic proximity Read ↗

Genetic predisposition of life-threatening antiepileptic-induced skin reactions.Semantic proximity Read ↗

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.Semantic proximity Read ↗

A Recent Update of Pharmacogenomics in Drug-induced Severe Skin ReactionsSemantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.Semantic proximity Read ↗

Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.